AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Impact of point-of-care pharmacist counseling at late refills of antiretroviral therapy: A Study Following the Early Warning Indicators of World Health Organization RecommendationsView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Raltigravir was non-superior to Lopinavir/ritonavir for treatment-experienced Chinese patients with HIV-1 infection: a 48-week randomized multicenter control studyView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Evolution of weight and lipid profiles in HIV-positive patients switched to coformulated elvitegravir/ cobicistat/emtricitabine/ tenofovir alafenamideView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Low prevalence of HLA-B*5701 and abacavir intolerance in HLA-B*5701 negative Thais with acute HIV infectionView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019The efficacy and safety of two-drug regimen including dolutegravir plus a boosted protease inhibitor in highly experienced HIV-infected patientsView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Effectiveness and Tolerability of Switch of Combination Antiretroviral Therapy to Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide among HIV-Positive TaiwaneseView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Efficacy and Safety of Doravirine in Treatment-Naïve Asian Adults with HIV-1View Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Six-year Immunologic Recovery and Virological Suppression of LPV/r-based Second-line Antiretroviral among HIV Patients: A Multi-center Real-world Cohort Study in ChinaView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Efficacy of dolutegravir (DTG) plus lamivudine (3TC) versus DTG plus tenofovir/emtricitabine (TDF/FTC) in antiretroviral treatment-naive adults with HIV-1 infection: 48-week subgroup results from the GEMINI studies in participants from Asian centersView Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Predictors of long-term survival in the TREAT Asia HIV Observational Database Low Intensity TransfEr (TAHOD-LITE)View Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019The impact of antiretroviral drug resistance in Taiwanese HIV-1-infected MSM population between 2015 and 2018View Abstract
AbstractHIVRSVViral Hepatitis and Liver DiseaseAPACC 2019Transmitted drug resistance to integrase inhibitors is uncommon in both acute and chronic HIV infection in BangkokView Abstract
